Public Policy

  • October 18, 2024

    1st Circ. OKs Prosecution Of Alleged Illicit Medical Pot Grow

    The First Circuit has determined that the federal prosecution of two Mainers accused of running an unlawful marijuana cultivation operation can continue despite a federal policy that bans the U.S. Department of Justice from bringing cases against medical cannabis entities.

  • October 18, 2024

    Enforcers Fight RealPage Transfer Bid In Rent-Fixing Case

    Enforcers urged a North Carolina federal court not to transfer the government's antitrust case against RealPage to the Tennessee court overseeing similar private cases, saying Congress has made it clear that public antitrust actions should not be roped into multidistrict litigation.

  • October 18, 2024

    Chamber Of Commerce Seeks Stay Of H-2A Rule For Harvest

    The U.S. Chamber of Commerce pushed a Mississippi federal court to stay a policy allowing H-2A migrant farmworkers to organize, saying its members can't risk being penalized under the policy while the Chamber challenges the rule's legality.

  • October 18, 2024

    Feds Defend Bribery Charge Against NYC Mayor Adams

    Federal prosecutors pushed back Friday on New York City Mayor Eric Adams' attempt to erase a bribery charge from his indictment, arguing that while Adams claims his acts were "routine" and allowed under a recent U.S. Supreme Court precedent, a jury could still find his alleged favor trading illegal.

  • October 18, 2024

    AGs Slam 4th Circ. Bid To Restore NC Abortion Drug Limits

    In a joint amicus brief to the Fourth Circuit, a coalition of 17 states and the District of Columbia has said the abortion drug mifepristone is a part of women's reproductive healthcare, assailing the "needless" limits that states including North Carolina have sought to impose on the drug's access.

  • October 18, 2024

    Suit Wants Fla. Abortion Measure Struck Over Fraud Claims

    A group of Florida voters represented by former Florida Supreme Court Justice Alan Lawson have filed suit to invalidate an abortion rights ballot measure over allegations of wide-scale fraud by the initiative's sponsor during the signature gathering process.

  • October 18, 2024

    Judge Blasts Feds' 'Utter Failure' To Quantify Climate Impact

    A Colorado federal judge has ruled the U.S. Army Corps of Engineers violated the Clean Water Act and other federal guidelines in approving a dredging permit for a Denver dam project, calling out the agency's "utter failure" to study the impacts of climate change and alternatives that would avoid impacting wetlands.

  • October 18, 2024

    Natural Gas Producer Will Pay $9.4M For Excess Air Pollution

    The U.S. Environmental Protection Agency and New Mexico Environment Department have reached a $9.4 million settlement with Hilcorp Energy Co., resolving claims the company failed to reduce emissions during well completion operations, in violation of the Clean Air Act and New Mexico state law.

  • October 18, 2024

    Chemical Cos. Say Firefighter Didn't Fix Standing In PFAS Suit

    3M Co. and two other chemical firms urged an Ohio federal judge to dismiss a firefighter's revised lawsuit over so-called forever chemicals, arguing that the allegations are plagued by the same shortcomings the Sixth Circuit flagged when it vacated class certification last year.

  • October 18, 2024

    Ore. Water Rights Issues Grounded In State Law, 9th Circ. Told

    The Klamath Irrigation District is asking the Ninth Circuit to certify two questions to the Oregon Supreme Court concerning the U.S. Bureau of Reclamation's authority to use and control the use of water under Oregon law.

  • October 18, 2024

    Minn. Tax Court Refuses Big Changes To Parking Lot's Value

    The Minnesota Tax Court lowered the assessed value of a parking lot property by about $200,000 to $11.7 million, rejecting arguments for larger changes by the property owner and a county.

  • October 18, 2024

    Mich. Supreme Court Spurns Challenge To UMich Gun Ban

    The Michigan Supreme Court declined Friday to review the constitutionality of the University of Michigan's campus firearms ban, leaving in place a lower court's ruling that the policy does not violate the Second Amendment.

  • October 18, 2024

    Commerce Dept. Eases Spacecraft Export Controls For Allies

    The U.S. Department of Commerce has issued a trio of rules intended to loosen controls on exports of spacecraft technology to U.S. allies, a move the department said was intended to help boost the U.S. commercial space industrial base.

  • October 18, 2024

    Pa. University Students Want Final OK For $1.15M Tuition Deal

    Students at St. Joseph's University in Philadelphia asked a federal court Friday for final approval of a $1.15 million settlement over tuition for classes that shifted online at the beginning of the COVID-19 pandemic.

  • October 18, 2024

    FERC Extension For Pipeline Spur Warranted, DC Circ. Told

    The developer of a southern spur of the Mountain Valley Pipeline and two potential customers are asking the D.C. Circuit to nix conservation groups' challenge of a construction deadline extension the Federal Energy Regulatory Commission granted for the so-called Southgate project.

  • October 18, 2024

    GOP Appeals Toss Of Ga.'s New Election Rules

    The Georgia and national Republican parties have moved to appeal a Fulton County judge's decision that declared as unconstitutional a slate of recent election rule changes made by the State Election Board.

  • October 18, 2024

    LA County DA Defends Progressive Policies In Reelection Bid

    George Gascón, the progressive Los Angeles County district attorney who's survived two recall efforts during his first term as top prosecutor, is standing by his reformist policies, which aim to curb mass incarceration and police misconduct, as he fights to keep his seat in November.

  • October 18, 2024

    57 Scholars, Former Judges Call For High Court Term Limits

    A group of 57 constitutional scholars and retired federal and state judges wrote a letter to the leaders of Congress on Wednesday urging them to establish term limits for U.S. Supreme Court justices, proposing guardrails that they said are "urgently needed at a time of plummeting confidence" in the nation's highest court.

  • October 18, 2024

    Expect Mental Health Parity Data Guidance, DOL Official Says

    The U.S. Department of Labor's employee benefits arm is working on guidance to help employer health plans comply with data collection and analysis requirements tied to recently finalized mental health and substance use disorder treatment coverage rules, an agency official told attorneys Friday.

  • October 18, 2024

    AG Taps DOJ Veteran To Lead Executive Office Of US Attys

    Attorney General Merrick B. Garland has chosen a longtime government lawyer to serve as director of the Executive Office for U.S. Attorneys, which serves as liaison between the U.S. Department of Justice and the country's 93 U.S. attorneys.

  • October 18, 2024

    Feds Win 1st Trial In Sprawling NYC Housing Bribery Case

    A former New York City Housing Authority superintendent was convicted of taking bribes to award no-bid contracts, handing federal prosecutors a win in the first trial in a case that saw 70 defendants arrested earlier this year.

  • October 18, 2024

    FTC Faces More Pressure To Block $16.5B Novo-Catalent Deal

    A dozen advocacy groups are pushing the Federal Trade Commission to block Novo Holdings' planned $16.5 billion purchase of Catalent, arguing that the deal would stifle competition for certain obesity and gene therapy drugs — and that no remedy can fix that.

  • October 17, 2024

    Monsanto Again Seeks Pause As Seattle PCB Trial Begins

    Monsanto is continuing its appellate bid to put off a chemical poisoning trial already underway in Washington state court as the plaintiffs told a Seattle jury on Thursday the company owes them more than $450 million, in the 10th such trial tied to an Evergreen State school.

  • October 17, 2024

    E-Cig Regs Are Congress' Job, Not FDA's, GOP Pols Tell Justices

    Republican lawmakers told the U.S. Supreme Court that Congress, not the U.S. Food and Drug Administration, should regulate flavored e-cigarettes, and that the regulator overstepped its authority by banning the sale of the vape products.

  • October 17, 2024

    Dems Sue FEC Over GOP's Alleged Ad Spending Tactics

    With less than 20 days until the election, the Democratic Congressional Campaign Committee filed a lawsuit against the Federal Election Commission on Thursday, alleging the agency should have stopped Republicans from using an advertising tactic that allows the party to get around spending limits.

Expert Analysis

  • 5 Defense Lessons From Prosecutors' Recent Evidence Flubs

    Author Photo

    The recent dismissal of Alec Baldwin’s involuntary manslaughter charges, and the filing of an ethics complaint against a former D.C. prosecutor, both provide takeaways for white collar defense counsel who suspect that prosecutors may be withholding or misrepresenting evidence, say Anden Chow at MoloLamken and Jonathan Porter at Husch Blackwell.

  • Mirror, Mirror On The Wall, Is My Counterclaim Bound To Fall?

    Author Photo

    A Pennsylvania federal court’s recent dismissal of the defendants’ counterclaims in Morgan v. Noss should remind attorneys to avoid the temptation to repackage a claim’s facts and law into a mirror-image counterclaim, as this approach will often result in a waste of time and resources, says Matthew Selmasska at Kaufman Dolowich.

  • Loper Fuels Debate Over Merchant Cash Advances As Credit

    Author Photo

    The U.S. Supreme Court's recent rejection of the Chevron doctrine in Loper Bright may escalate a Florida federal court dispute between the Revenue Based Finance Coalition and the Consumer Financial Protection Bureau over whether merchant cash advances should be considered credit under the Dodd-Frank Act, say attorneys at Sheppard Mullin.

  • Bank M&A Continues To Lag Amid Regulatory Ambiguity

    Author Photo

    Bank M&A activity in the first half of 2024 continued to be lower than in prior years, as the industry is recovering from the 2023 bank failures, and regulatory and macroeconomic conditions have not otherwise been prime for deals, say Robert Azarow and Amber Hay at Arnold & Porter.

  • FTC's Drug Middlemen Probe Highlights Ongoing Scrutiny

    Author Photo

    The Federal Trade Commission's interim staff report on its inquiry into pharmacy benefit managers suggests that the industry will remain under an enforcement microscope for the foreseeable future due to concerns about how PBMs affect drug costs and accessibility, say attorneys at Arnold & Porter.

  • How High Court Ruling Is Shaping Homelessness Policies

    Author Photo

    The U.S. Supreme Court’s June decision in Grants Pass v. Johnson to allow enforcement of local ordinances against overnight camping is already spurring new policies to manage homelessness, but the court's ruling does not grant jurisdictions unfettered power, say Kathryn Kafka and Alex Merritt at Sheppard Mullin.

  • DOJ Paths To Limit FARA Fallout From Wynn's DC Circ. Win

    Author Photo

    After the D.C. Circuit’s recent Attorney General v. Wynn ruling, holding that the government cannot compel retroactive registration under the Foreign Agents Registration Act, the U.S. Department of Justice has a few options to limit the decision’s impact on enforcement, say attorneys at MoFo.

  • Series

    Playing Dungeons & Dragons Makes Me A Better Lawyer

    Author Photo

    Playing Dungeons & Dragons – a tabletop role-playing game – helped pave the way for my legal career by providing me with foundational skills such as persuasion and team building, says Derrick Carman at Robins Kaplan.

  • A Look At The Regulatory Scrutiny Facing Liquid Restaking

    Author Photo

    Recent U.S. Securities and Exchange Commission enforcement actions highlight the regulatory challenges facing emerging financial instruments like liquid restaking tokens and services, say Daniel Davis and Alexander Kim at Katten.

  • Del. Dispatch: Director Caremark Claims Need Extreme Facts

    Author Photo

    The Delaware Court of Chancery recently dismissed Caremark claims against the directors of Centene in Bricklayers Pension Fund of Western Pennsylvania v. Brinkley, indicating a high bar for a finding of the required element of bad faith for Caremark liability, and stressing the need to resist hindsight bias, say attorneys at Fried Frank.

  • Series

    After Chevron: Challenges Loom For PBGC Actions

    Author Photo

    After Loper Bright, two recent actions taken by the Pension Benefit Guaranty Corp. already under scrutiny seem destined to be challenged and resolved under the new standard of judicial deference, which will greatly affect employers with potential withdrawal liability exposure, say Robert Perry and David Pixley at Jackson Lewis.

  • Opinion

    USPTO AI Patent Guidance Leaves Questions Unanswered

    Author Photo

    The U.S. Patent and Trademark Office’s recent guidance on artificial intelligence patent eligibility is unlikely to answer many of the open questions that AI patent applicants face, as it includes nominally new analysis that applicants can adopt to analyze their inventions, say attorneys at Fenwick & West.

  • Illinois BIPA Reform Offers Welcome Relief To Businesses

    Author Photo

    Illinois' recent amendment to its Biometric Information Privacy Act limits the number of violations and damages a plaintiff can claim — a crucial step in shielding businesses from unintended legal consequences, including litigation risk and compliance costs, say attorneys at Taft.

  • Unpacking Executive Privilege, Contempt In Recent Cases

    Author Photo

    The U.S. House of Representatives’ recent move to hold Attorney General Merrick Garland in contempt of Congress is the latest example in a growing trend of executive privilege disputes, and serves as a warning to private citizens and corporate leaders who are in communication with the president, says Kristina Moore at Womble Bond.

  • Gilead Drug Ruling Creates Corporate Governance Dilemma

    Author Photo

    If upheld, a California state appellate court's decision — finding that Gilead is liable for delaying commercialization of a safer HIV drug to maximize profits on another drug — threatens to undermine long-standing rules of corporate law and exposes companies to liability for decisions based on sound business judgment, says Shireen Barday at Pallas.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Public Policy archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!